The trademark application LUZYRVO was filed by Johnson & Johnson, a U.S. corporation (the "Applicant"). The application was published for oppositions on August 21, 2022, and it was registered by office on November 28, 2022 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 19, 2022.
Goods And Services
The mark was filed in class 5 with following description of goods:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases